How To Use HCPCS Code G9033

HCPCS code G9033 describes the oral brand of amantadine hydrochloride, per 100 mg, specifically for use in a Medicare-approved demonstration project. This code was terminated on December 31, 2019, and is no longer maintained. In this article, we will explore the details of HCPCS code G9033, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS G9033?

HCPCS code G9033 is a specific code used to identify the oral brand of amantadine hydrochloride, per 100 mg, for use in a Medicare-approved demonstration project. It is important to note that this code is no longer maintained and was terminated on December 31, 2019.

2. Official Description

The official description of HCPCS code G9033 is “Amantadine hydrochloride, oral brand, per 100 mg (for use in a Medicare-approved demonstration project)”. The short description for this code is “Amantadine hcl oral brand”.

3. Procedure

1. Administer the oral brand of amantadine hydrochloride to the patient.
2. Ensure the dosage is 100 mg per administration.
3. Document the administration of the medication in the patient’s medical record.

4. When to use HCPCS code G9033

HCPCS code G9033 should be used when administering the oral brand of amantadine hydrochloride, specifically for use in a Medicare-approved demonstration project. It is important to verify the eligibility criteria and guidelines for using this code, as it may vary depending on the specific project or program.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code G9033, healthcare providers should ensure the following documentation requirements are met:

• Documentation of the patient’s eligibility for the Medicare-approved demonstration project.
• Documentation of the administration of the oral brand of amantadine hydrochloride, including the dosage and frequency.
• Any additional documentation required by the specific project or program.

6. Historical Information and Code Maintenance

HCPCS code G9033 was added to the Healthcare Common Procedure Coding System on December 01, 2004. It had an effective date until December 31, 2019. This code is no longer maintained, as indicated by the action code N, which means no maintenance for this code.

7. Medicare and Insurance Coverage

HCPCS code G9033 may have coverage under Medicare or other insurance plans. The pricing indicator code for this code is 13, which indicates that the price is established by carriers, based on carrier discretion. The multiple pricing indicator code is A, indicating that it is not applicable as HCPCS priced under one methodology. It is important to check with Medicare or the specific insurance plan for coverage and reimbursement details.

8. Examples

Here are five examples of when HCPCS code G9033 should be billed:

1. A patient enrolled in a Medicare-approved demonstration project receives the oral brand of amantadine hydrochloride, per 100 mg, as part of the project’s treatment protocol.
2. A healthcare provider administers the oral brand of amantadine hydrochloride, per 100 mg, to a patient participating in a specific Medicare demonstration project.
3. A patient with a qualifying medical condition receives the oral brand of amantadine hydrochloride, per 100 mg, as part of a research study approved by Medicare.
4. A healthcare provider administers the oral brand of amantadine hydrochloride, per 100 mg, to a patient enrolled in a Medicare-approved demonstration project for the treatment of a specific condition.
5. A patient receives the oral brand of amantadine hydrochloride, per 100 mg, as part of a clinical trial approved by Medicare.